Legal, Regulatory Matters and Contingencies (Details)					1 Months Ended		3 Months Ended
	Jan. 14, 2020 USD ($)	May 22, 2019 USD ($)	May 10, 2019 employee company	Dec. 31, 2016 company	Aug. 31, 2019 USD ($) product	Nov. 30, 2016 item	Sep. 30, 2020 lawsuit state product Distributor tranche	Jun. 30, 2018 product	Oct. 31, 2017 product
Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs							1
State Attorneys General Inquiry into The Generic Pharmaceutical Industry
Legal, Regulatory Matters and Contingencies
Number of manufacturers and distributors | company			33	6
Number of drugs									13
Number of officers | employee			1
State Attorneys General Inquiry into The Generic Pharmaceutical Industry | Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs									1
Government Pricing
Legal, Regulatory Matters and Contingencies
Settlement payment | $		$ 9,400,000
Reimbursement of overpayment | $					$ 8,100,000
Private Antitrust and Consumer Protection Litigation
Legal, Regulatory Matters and Contingencies
Number of manufacturers and distributors | Distributor							30
Number of drugs					135		18		6
Number of Tranches | tranche							3
Number of States | state							49
Private Antitrust and Consumer Protection Litigation | Minimum
Legal, Regulatory Matters and Contingencies
Number of lawsuits | lawsuit							100
End Payer Plaintiffs
Legal, Regulatory Matters and Contingencies
Number of drugs								14
Indirect Reseller Plaintiffs
Legal, Regulatory Matters and Contingencies
Number of drugs								15
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers | item						2
Litigation settlement amount payable to other party | $	$ 600,000